Heritability of aortic valve stenosis and bicuspid enrichment in families with aortic valve stenosis.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 07 2022
Historique:
received: 19 01 2022
revised: 10 03 2022
accepted: 08 04 2022
pubmed: 16 4 2022
medline: 7 6 2022
entrez: 15 4 2022
Statut: ppublish

Résumé

Although a familial component of calcific aortic valve stenosis (CAVS) has been described, its heritability remains unknown. Hence, we aim to assess the heritability of CAVS and the prevalence of bicuspid aortic valve among CAVS families. Probands were recruited following aortic valve replacement (AVR) for severe CAVS on either tricuspid (TAV) or bicuspid aortic valve (BAV). After screening, relatives underwent a Doppler-echocardiography to assess the aortic valve morphology as well as the presence and severity of CAVS. Families were classified in two types according to proband's aortic valve phenotype: TAV or BAV families. Control families were recruited and screened for the presence of BAV. Among the 2371 relatives from 138 CAVS families (pedigree cohort), heritability of CAVS was significant (h Our study confirms the heritability of CAVS in both TAV and BAV families, suggesting a genetic background of this frequent valvular disease. In addition, BAV enrichment in TAV families suggests an interplay between tricuspid CAVS and BAV. Overall results support the need to improve phenotyping (i.e. BAV, TAV, risk factors) in CAVS families in order to enhance the identification of rare and causal genetic variants of CAVS. NCT02890407.

Sections du résumé

BACKGROUND
Although a familial component of calcific aortic valve stenosis (CAVS) has been described, its heritability remains unknown. Hence, we aim to assess the heritability of CAVS and the prevalence of bicuspid aortic valve among CAVS families.
METHODS
Probands were recruited following aortic valve replacement (AVR) for severe CAVS on either tricuspid (TAV) or bicuspid aortic valve (BAV). After screening, relatives underwent a Doppler-echocardiography to assess the aortic valve morphology as well as the presence and severity of CAVS. Families were classified in two types according to proband's aortic valve phenotype: TAV or BAV families. Control families were recruited and screened for the presence of BAV.
RESULTS
Among the 2371 relatives from 138 CAVS families (pedigree cohort), heritability of CAVS was significant (h
CONCLUSIONS
Our study confirms the heritability of CAVS in both TAV and BAV families, suggesting a genetic background of this frequent valvular disease. In addition, BAV enrichment in TAV families suggests an interplay between tricuspid CAVS and BAV. Overall results support the need to improve phenotyping (i.e. BAV, TAV, risk factors) in CAVS families in order to enhance the identification of rare and causal genetic variants of CAVS.
CLINICAL TRIALS IDENTIFIER
NCT02890407.

Identifiants

pubmed: 35427703
pii: S0167-5273(22)00501-0
doi: 10.1016/j.ijcard.2022.04.022
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02890407']

Types de publication

Clinical Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-98

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Anne-Sophie Boureau (AS)

Department of Geriatrics, University Hospital, Nantes, France; l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.. Electronic address: annesophie.boureau@chu-nantes.fr.

Matilde Karakachoff (M)

CHU Nantes, INSERM, CIC 1413, France.

Solena Le Scouarnec (S)

l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.

Romain Capoulade (R)

l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.

Caroline Cueff (C)

l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.

Laure de Decker (L)

Department of Geriatrics, University Hospital, Nantes, France.

Thomas Senage (T)

Service de chirurgie Thoracique et CardioVasculaire, CHU Nantes, Nantes, France.

Jean-Philippe Verhoye (JP)

Service de chirurgie cardio vasculaire, Hopital Pontchaillou, Inserm 1099, Rennes, France.

Christophe Baufreton (C)

Dpt of Cardio-Vascular and Thoracic Surgery, University Hospital of Angers, CNRS UMR 6015, INSERM U1083, France.

Jean-Christian Roussel (JC)

Service de chirurgie Thoracique et CardioVasculaire, CHU Nantes, Nantes, France.

Christian Dina (C)

l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.

Vincent Probst (V)

l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.

Jean-Jacques Schott (JJ)

l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.

Thierry Le Tourneau (T)

l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.. Electronic address: thierry.letourneau@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH